 Home > Active Ingredient News > Antitumor Therapy > Front Oncol: Differences in clinical characteristics and clinical prognosis of patients with non-metastatic non-clear cell renal cell carcinoma (non-ccRCC)

Front Oncol: Differences in clinical characteristics and clinical prognosis of patients with non-metastatic non-clear cell renal cell carcinoma (non-ccRCC)

 Last Update: 2022-01-23
 Source: Internet
 Author: User

Tags

cell encapsulation

non animal protein

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Non-clear cell renal cell carcinoma (non-ccRCC) includes histologically and molecularly distinct subtypes, such as papillary, chromophobe, collecting duct, and sarcomatoid RCC, with an incidence of 20% to 25%

The study used the National Cancer Database to screen patients with non-metastatic RCC (T1-4, N0-1) between 2004 and 2015

Overall, our analysis included 220,170 patients with RCC

The median follow-up time for patients with all histological subtypes was 48.

Differences in prognosis of non-clear cell renal cell carcinoma (non-ccRCC) subtypes

Multivariate analysis included 6723 chromophobe, 188 collecting duct, 19086 papillary, and 1083 sarcomatoid RCC

Well-differentiated (HR = 0.

In terms of surgical treatment, no surgery (HR = 2.

Regional lymph node surgery was associated with worse survival outcomes compared with surgery without regional lymph nodes (HR = 1.

Taken together, our study demonstrated that collecting duct and sarcoid histological subtypes are less common and associated with poorer postoperative survival compared with other RCC subtypes

Original source:

An J, Packiam VT, Chennamadhavuni A, Richards J, Jain J, Mott SL and Garje R (2022) Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma.

An J, Packiam VT, Chennamadhavuni A, Richards J, Jain J, Mott SL and Garje R (2022) Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma.
Front.
Oncol.
11:786307.
doi : 10.
3389/fonc.
2021.
786307

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Factory Supply Veliparib HCL 99% Powder CAS 912445-05-7 EGC-Veliparib HCL Price

CAS No.: 912445-05-7

Pesticide Grade

$110-115/KG FOB

Evodiamine Pharmaceutical Grade CAS 518-17-2 Evodiamine powder

CAS No.: 518-17-2

Pharmacy Grade

$90-100/KG FOB

Daunorubicin

CAS No.: 20830-81-3

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.